The National Cancer Institute (NCI) has awarded $1.7 million to support the work of a University of Arkansas for Medical Sciences (UAMS) researcher in developing a therapy that can preserve bone health, and prevent or delay cancer relapse in people with multiple myeloma. This form of blood cancer causes malignant cancer cells to accumulate in the bone marrow, the soft spongy tissue found inside bones, progressively damaging the bones and causing them to become weaker…
You must be logged in to read/download the full post.
The post NCI Awards $1.7M for Bone Therapy Research to Prevent or Delay Cancer Relapse appeared first on BioNewsFeeds.